FDA Investigator Jennifer C Adams

Jennifer C Adams has conducted inspections on 126 sites in 7 countries as of 13 Mar 2023. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
126
Last Inspection Date:
13 Mar 2023
Investigator Role:
FDA Investigator
Redica ID:
100008301
Countries of Inspections:
United States of America, India, Mexico, Guatemala, Jordan, Germany, Bulgaria
FDA Investigators that have inspected at least one site in common with Jennifer C Adams:
Adam J Taylor, Alan M Roberts, Alan P Kurtzberg, Alanna L Mussawwir Bias, Alicia M Mozzachio, Allen F Hall, Amanda B Vega, Amanda E Lewin, PhD, Amanda S Zorn, Amy Devlin, PhD, Amy Wyan Mai, Ana L Kewes, Anastasia M Shields, Anders W Evenson, Andrew A Leboeuf, Andrew Le, Angela E Glenn, Anjali Shukla, PhD, Arindam Dasgupta, PhD, Arsen Karapetyan, Atul J Agrawal, Barbara A Rusin, Barbara J Rincon, Barbara Janine Breithaupt, Barbara M Frazier, Bradley J Maunder, Brandy D Brown, Brentley S Collins, Brian D Nicholson, Brian P Emanuel, Brittani N Franklin, Bruce H Mccullough, Bryan L Mcguckin, Camille D Brown, Carl A Huffman, III, Carmen Y Fisher, Carol F Robinson, Carrie Ann Plucinski, Celeta S Coves, Chad E Schmear, Charanjeet Jassal, Charles A Snipes, PhD, Cheryl A Clausen, Christina A Miller, Christopher D Leach, Clotia Cabbey Mensah, Colleen E Burke, Corey K Reno, Courtney N Long, Craig A Garmendia, Daniel B Arrecis, Daniel L Aisen, Dariusz Galezowski, Darla J Christopher, Debra I Love, Debra Lboyd Seale, Decarlos A Gomez, Demitria J Xiradakis, Donna A Katz, Doretha M Tonkins, Dr. Gopa Biswas, PhD, Dr. Mark J Seaton, PhD, Dr. Zhou Chen (nmi), MD PhD, Edmund F Mrak, Jr, Elizabeth L Holmes, Emily S Mcgann, Eric M Mueller, PharmD, Eric S Pittman, Erin M Mcdowell, Erma Zaimova, Esther A Ofori, Farhana Khan, Frank Wackes, Frederick F Razzaghi, Gabryelle J Solverud, Gajendiran Mahadevan, PhD, Gene R Gunn, Geoffrey K Kilili, Gwyn G Dickinson, Hanna L Potter, Hasan A Irier, PhD, Helen Verdel, Hoimay Chan, Humera T Khan, James L Finn, James P Duggan, James W Plucinski, Jane M Kreis, Janete F Guardia, Jason F Chancey, Jeanne J Chiu, Jeanne J Thai, Jeanne M Morris, Jeffrey W Shrifter, DPM, Jennifer A D'angelo, Jennifer Adams, MPH, Jennifer C Johnson, Jesse A Vazquez, Jessica L Burley, Jogy George, John A Iwen, Jonathan G Swoboda, Jose M Cayuela, Jose R Hernandez, Julian C Hanson, Jyoti B Patel, PhD, Kara A Scheibner, PhD, Karen Emasley Joseph, Katherine Szestypalow, Kathleen A Schelble, Kathleen S Tormey, Kellia N Hicks, Kenneth L Smalls, Kent A Conforti, Kent C Faul, Kimberly A Dux, Kip J Hanks, Kristen E Szenderski, Kujtim Sadiku, Lakecha N Lewis, Latoya A Griffith, Lauren A Crivellone, Laurie A Haxel, Laverne Puckett, LCDR Mark A Jimenez, RN, Lee Terry Moore, Lequita M Mayhew, Lesley Maep Lutao, Leslie D Hintz, Li Hongpaul Yeh, PhD, Linda Thai, Lisa Hayka, Lisa Hornback, Lori A Gioia, Luis A Dasta, Makini Cobourne Duval, PhD, Marcia A Worley, Margaret Torres Vazquez, Maria Diaz, Maria Gutierrez Lugo, PhD, Marisa E Stock, Mark G Peterson, Martin R Vowell, Matthew B Casale, Matthew C Watson, Matthew J Gretkierewicz, Matthew J Sienko, Melkamu Getie Kebtie, PhD, Merry Christie, PhD, Michael A Charles, Michael D Robinson, Michael Shanks, MS, Michele L Glendenning, Michele Perry Williams, Milva E Melendez Perales, Minh D Phan, Mra V Millarw, Muralidhara B Gavini, PhD, Myla D Chapman, Nadeem I Chaudhry, Nancy A Bellamy, Neali H Lucas, Nicholas F Lyons, Nicola M Fenty Stewart, Nicole C Victoria, PhD, Nicole E Knowlton, Omotunde O Osunsanmi, Pablo Alcantara, Paraluman S Leonin, Parul M Patel, Patricia A Mcilroy, Paul M Chefor, Paula A Trost, Paula J Bretz, Peng Zhou, Perry H Gambrell, Peter R Lenahan, Philip F Istafanos, DMV, MS, Phung Thien Nguyen, Pratik S Upadhyay, DDC, Rafael Padilla, Ralph A Erickson, Randy D Baxter, Reba A Gates, Rebecca T Davis, Reyes Candau Chacon, PhD, Robert J Doyle, Robert J Nesselhauf, Roberta W Cunningham, Roger J Adams, Ronda Rloyd Jones, Rose Ljean Mary, Rosemary Wood Sexton, Roshni J Patel, Ruben C Ayala, PharmD, Russell K Riley, S Lori Brown, PhD MPH, Sam H Haidar, PhD, Samuel W Labinjo, Sangeeta M Khurana, PhD, Sarah Forney, Sarah L Roman, Sarah Nwandiuko, Scott B Laufenberg, Scott R Nichols, PhD, Shalonda C Clifford, Shana L Williams, Sharon K Thoma, PharmD, Sherea L Dillon, Sheri L Stephenson, Shirley H Isbill, Sony Mathews, Sripal R Mada, PhD, Stacey S Degarmo, Stephanie Mangigian, MS/OSH, RN, Stuart W Russell, Sullan, Sunitha K Rajaram, PhD, Susan D Yuscius, Susan M Jackson, Susan P Bruederle, Susan W Ciani, Susanne M Richardson, MS RAC, Tamara M Qtami, Tamara Qtami, Tamil Arasu, PhD, Tara A Marshall, Tara C Alcazar, Tara K Carmody, Tara R Gooen, Tawny L Colling, Thea C Grome, Theressa B Smith, Thomas J Arista, Thunder N Dunkijacobs, Timothy C Grome, Todd M Stankewicz, Tong Zhou, Travis S Bradley, Uruaku A Obasi, Vickie J Kanion, Victoria M Daddeo, Vivin George, Wayne E Seifert, Wayne W Grundstrom, Wendy G Tan, PhD, Xiaokuang Lai, PhD, Xikui Chen (nmi), PhD, Young M Choi, PhD, Yuanyuan Li, Yvonne C Wilkes, Yvonne E Lozano, Zerita White, Zoey A Trombley

Jennifer C Adams's Documents

Publish Date Document Type Title
July, 2016 FDA 483 Response Richard K. Burt - Form 483R, 2016-07-22
March, 2013 EIR Balin, Martin S., MD, PhD - EIR, 2013-03-13
November, 2015 FDA 483 Azazuddin A. Ahmed, MD - Form 483, 2015-11-30
January, 2014 FDA 483 Response Danny H. Sugimoto, M.D. - Form 483R, 2014-01-14
February, 2020 FDA 483 William J. Gradishar, M.D. - Form 483, 2020-02-28
October, 2019 FDA 483 Takeda Pharmaceuticals USA, Inc. - Form 483, 2019-10-25
March, 2013 FDA 483 Fresh Express - Form 483, 2013-03-21
July, 2016 FDA 483 Richard K. Burt - Form 483, 2016-07-11
June, 2014 FDA 483 Response Hodgson, Kim J., M.D. - Form 483R, 2014-06-25
June, 2014 FDA 483 Hodgson, Kim J., M.D. - Form 483, 2014-06-12
June, 2018 FDA 483 Unichem Laboratories Limited - Form 483, 2018-06-29
January, 2017 FDA 483 Peter O'Donnell - Form 483, 2017-01-19
October, 2017 FDA 483 Shivam Hospital - Form 483, 2017-10-18
August, 2018 FDA 483 Sanjay Gupta - Form 483, 2018-08-24
January, 2014 EIR Danny H. Sugimoto, M.D. - EIR, 2014-01-02
August, 2018 FDA 483 Response Aurobindo Pharma Limited - Form 483R, 2018-08-10
December, 2013 FDA 483 Response Alexian Brothers Hospital Network IRB - Form 483R, 2014-01-30
July, 2016 EIR Richard K. Burt - EIR, 2016-07-11
August, 2014 EIR Paul W. Crawford, MD - EIR, 2014-08-18
August, 2014 FDA 483 Paul W. Crawford, MD - Form 483, 2014-08-18
October, 2017 FDA 483 Medilink Hospital and Research Center - Form 483, 2017-10-13
November, 2014 FDA 483 Dr. Luis Demetrio Gonzalez Patzan - Form 483, 2014-11-14
March, 2018 FDA 483 BIOCON LIMITED - Form 483, 2018-03-16
February, 2014 EIR Dr. Narendra Khippal - EIR, 2014-02-07
March, 2013 FDA 483 Balin, Martin S., MD, PhD - Form 483, 2013-03-13
May, 2015 FDA 483 Response Danny H. Sugimoto, M.D. - Form 483R, 2015-06-09
February, 2020 FDA 483 Copley Memorial Hospital - Form 483, 2020-02-10
May, 2015 FDA 483 Danny H. Sugimoto, M.D. - Form 483, 2015-05-20
January, 2014 EIR Azazuddin A. Ahmed, MD - EIR, 2014-01-23
September, 2016 FDA 483 Joseph R. Lentino, M.D. - Form 483, 2016-09-20
April, 2019 EIR Azazuddin A. Ahmed, MD - EIR, 2019-04-30
August, 2018 EIR Aurobindo Pharma Limited - EIR, 2018-08-10
August, 2014 FDA 483 Response Paul W. Crawford, MD - Form 483R, 2014-09-08
November, 2015 EIR Azazuddin A. Ahmed, MD - EIR, 2015-11-30
January, 2014 FDA 483 Danny H. Sugimoto, M.D. - Form 483, 2014-01-02
August, 2014 FDA 483 Satya P. Ahuja - Form 483, 2014-08-18
April, 2019 FDA 483 Azazuddin A. Ahmed, MD - Form 483, 2019-04-30
May, 2015 EIR Danny H. Sugimoto, M.D. - EIR, 2015-05-20
April, 2015 EIR Hospira, Inc. - EIR, 2015-04-13
October, 2019 FDA 483 Richard Bernstein, MD, PhD - Form 483, 2019-10-10
August, 2016 EIR Experimur, A Frontage Company - EIR, 2016-08-26
December, 2013 EIR Alexian Brothers Hospital Network IRB - EIR, 2013-12-12
April, 2015 FDA 483 Response Hospira, Inc. - Form 483R, 2015-05-01
May, 2017 FDA 483 MICRO THERAPEUTIC RESEARCH LABS PRIVATE LIMITED - Form 483, 2017-05-24
October, 2018 FDA 483 Vimta Labs Limited - Form 483, 2018-10-26
August, 2017 FDA 483 Lotus Labs Private Limited - Form 483, 2017-08-22
October, 2016 FDA 483 IIT Research Institute - Form 483, 2016-10-26
September, 2014 FDA 483 Larson, Richard A., M.D. - Form 483, 2014-09-05
September, 2016 EIR Joseph R. Lentino, M.D. - EIR, 2016-09-20
June, 2016 FDA 483 Stephen C. Jensik - Form 483, 2016-06-09
November, 2015 FDA 483 Response Azazuddin A. Ahmed, MD - Form 483R, 2015-12-14
August, 2018 FDA 483 Aurobindo Pharma Limited - Form 483, 2018-08-10
September, 2014 EIR Larson, Richard A., M.D. - EIR, 2014-09-05
September, 2014 FDA 483 Response Larson, Richard A., M.D. - Form 483R, 2014-10-02
September, 2016 FDA 483 Response Joseph R. Lentino, M.D. - Form 483R, 2016-10-10
December, 2013 FDA 483 Alexian Brothers Hospital Network IRB - Form 483, 2013-12-12
April, 2015 FDA 483 Hospira, Inc. - Form 483, 2015-04-13

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more